WKY/NHsd |
skin potassium level plus skin sodium level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin mineral amount |
male |
0 days
| 8 |
0.17 |
null |
0.0 |
0.01 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
0 |
ashed skin |
skin na+k/h2o |
99146 |
2238 |
WKY/NHsd |
skin chloride level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
0 days
| 7 |
48.0 |
mmol/l |
4.8 |
12.7 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
0 |
ashed skin |
skin cl/h2o |
99153 |
2238 |
WKY/NHsd |
plasma cystatin C level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood cystatin C amount |
male |
0 days
| 8 |
3.9 |
mg/l |
0.3 |
0.85 |
automated plasma protein analysis |
0.0 |
0 |
|
|
99178 |
2238 |
WKY/NHsd |
creatinine clearance |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
glomerular filtration trait |
male |
0 days
| 8 |
3.5 |
ml/min |
0.2 |
0.57 |
urine creatinine analysis |
0.0 |
0 |
|
|
99182 |
2238 |
WKY/NHsd |
skin water level to skin dry weight ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin water amount |
male |
0 days
| 7 |
1.43 |
ml/g |
0.03 |
0.08 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
0 |
ashed skin |
skin h2o ml/g |
99141 |
2238 |
WKY/NHsd |
plasma chloride level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood chloride amount |
male |
0 days
| 8 |
109.1 |
mmol/l |
1.0 |
2.83 |
automated blood electrolyte analysis |
0.0 |
0 |
|
|
99170 |
2238 |
WKY/NHsd |
skin potassium level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin potassium amount |
male |
0 days
| 7 |
71.0 |
mmol/l |
3.0 |
7.94 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
0 |
ashed skin |
skin k/h2o |
99157 |
2238 |
WKY/NHsd |
plasma sodium level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood sodium amount |
male |
0 days
| 7 |
141.4 |
mmol/l |
2.1 |
5.56 |
automated blood electrolyte analysis |
0.0 |
0 |
|
|
99161 |
2238 |
WKY/NHsd |
plasma potassium level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood potassium amount |
male |
0 days
| 8 |
4.4 |
mmol/l |
0.4 |
1.13 |
automated blood electrolyte analysis |
0.0 |
0 |
|
|
99166 |
2238 |
WKY/NHsd |
skin sodium level to skin dry weight ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin sodium amount |
male |
0 days
| 8 |
0.16 |
REQUEST NEW VALUE |
0.01 |
0.03 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
0 |
ashed skin |
mmol/g |
99134 |
2238 |
WKY/NHsd |
skin chloride level to skin dry weight ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
0 days
| 8 |
0.07 |
mmol/g |
0.01 |
0.02 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
0 |
ashed skin |
skin cl mmol/g |
99138 |
2238 |
WKY/NHsd |
skin chloride level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
0 days
| 8 |
108.0 |
mmol/l |
4.4 |
12.45 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
0 |
ashed skin |
skin na/h2o |
99150 |
2238 |
WKY/NHsd |
plasma cystatin C level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood cystatin C amount |
male |
0 days
| 7 |
3.5 |
mg/l |
0.2 |
0.53 |
automated plasma protein analysis |
0.0 |
0 |
|
|
99177 |
2238 |
WKY/NHsd |
plasma chloride level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood chloride amount |
male |
0 days
| 7 |
104.8 |
mmol/l |
1.8 |
4.76 |
automated blood electrolyte analysis |
0.0 |
0 |
|
|
99169 |
2238 |
WKY/NHsd |
urine sodium excretion rate |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
urine sodium amount |
male |
0 days
| 7 |
41.9 |
mEq/d |
5.2 |
13.76 |
urine sodium analysis |
0.0 |
0 |
|
|
99185 |
2238 |
WKY/NHsd |
skin chloride level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
0 days
| 7 |
101.0 |
mmol/l |
3.9 |
10.32 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
0 |
ashed skin |
skin na/h2o |
99149 |
2238 |
WKY/NHsd |
skin chloride level to skin dry weight ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
0 days
| 7 |
0.07 |
mmol/g |
0.01 |
0.02 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
0 |
ashed skin |
skin cl mmol/g |
99137 |
2238 |
WKY/NHsd |
plasma creatinine level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood creatinine amount |
male |
0 days
| 7 |
0.3 |
mg/dl |
0.01 |
0.02 |
plasma creatinine analysis |
0.0 |
0 |
|
|
99173 |
2238 |
WKY/NHsd |
mean arterial blood pressure |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
arterial blood pressure trait |
male |
0 days
| 7 |
116.0 |
mmHg |
1.0 |
2.65 |
intra-aortic radiotelemetry |
0.0 |
0 |
|
|
99189 |
2238 |
WKY/NHsd |
plasma creatinine level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood creatinine amount |
male |
0 days
| 8 |
0.32 |
mg/dl |
0.01 |
0.03 |
plasma creatinine analysis |
0.0 |
0 |
|
|
99174 |
2238 |
WKY/NHsd |
urine sodium excretion rate |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
urine sodium amount |
male |
0 days
| 8 |
34.3 |
mEq/d |
1.8 |
5.09 |
urine sodium analysis |
0.0 |
0 |
|
|
99186 |
2238 |
WKY/NHsd |
skin potassium level plus skin sodium level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin mineral amount |
male |
0 days
| 7 |
0.18 |
null |
0.01 |
0.02 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
0 |
ashed skin |
skin na+k/h2o |
99145 |
2238 |
WKY/NHsd |
skin potassium level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin potassium amount |
male |
0 days
| 8 |
69.0 |
mmol/l |
2.5 |
7.07 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
0 |
ashed skin |
skin k/h2o |
99158 |
2238 |
WKY/NHsd |
skin water level to skin dry weight ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin water amount |
male |
0 days
| 8 |
1.52 |
ml/g |
0.0 |
0.01 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
0 |
ashed skin |
skin h2o ml/g |
99142 |
2238 |
WKY/NHsd |
creatinine clearance |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
glomerular filtration trait |
male |
0 days
| 7 |
3.5 |
ml/min |
0.3 |
0.79 |
urine creatinine analysis |
0.0 |
0 |
|
|
99181 |
2238 |
WKY/NHsd |
skin sodium level to skin dry weight ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin sodium amount |
male |
0 days
| 7 |
0.14 |
REQUEST NEW VALUE |
0.01 |
0.01 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
0 |
ashed skin |
mmol/g |
99133 |
2238 |
WKY/NHsd |
plasma sodium level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood sodium amount |
male |
0 days
| 8 |
139.4 |
mmol/l |
1.7 |
4.81 |
automated blood electrolyte analysis |
0.0 |
0 |
|
|
99162 |
2238 |
WKY/NHsd |
plasma potassium level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood potassium amount |
male |
0 days
| 7 |
4.2 |
mmol/l |
0.3 |
0.79 |
automated blood electrolyte analysis |
0.0 |
0 |
|
|
99165 |
2238 |
WKY/NHsd |
skin chloride level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
0 days
| 8 |
50.0 |
mmol/l |
4.4 |
12.45 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
0 |
ashed skin |
skin cl/h2o |
99154 |
2238 |
WKY/NHsd |
mean arterial blood pressure |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
arterial blood pressure trait |
male |
0 days
| 8 |
124.0 |
mmHg |
4.0 |
11.31 |
intra-aortic radiotelemetry |
0.0 |
0 |
|
|
99190 |
2238 |